Search results for: 'EndPoint Detection and Response'

Stroke remains the leading cause of long-term disability and mortality worldwide, with every minute of delayed diagnosis resulting in irreversible neuronal damage. Recent advancements in AI-powered imaging and portable diagnostic devices are transforming the stroke diagnosis landscape by enabling rapid, decentralized, and data-driven assessment. Th...

Pharmaceutical companies spend billions of dollars in drug development because of expensive and time-consuming clinical trials, with a meager success rate. Frequent clinical visits, manual data processing, and a lack of consistent data on the effectiveness of the investigation of medical products contribute to their low success rate. Digital bio...

The rise in both global population and travel is contributing to the increase in spread of infectious diseases. Rapid and accurate identification of the infectious pathogens are imperative for timely intervention, better patient outcomes, and control and management of the spread of the infection. Conventional infectious disease diagnoses are perfor...

The global clinical diagnostics market is poised for strong growth as stakeholders shift focus toward high-growth segments such as precision medicine, decentralized diagnostics, software-driven solutions, and product expansion. Companies continue to adopt LIMS and other digital platforms while emerging opportunities in the POCT sector further drive...

A digital biomarker refers to measurable data about physiological functions or behaviors collected through digital devices and technologies, such as wearables, implants, ingestible sensors, smartphones, and mobile applications. These biomarkers provide continuous, real-time insights into an individual’s health status and are used to monitor normal ...

The molecular diagnostics industry is undergoing consolidation, requiring capital investment and faster regulatory pathways to accelerate clinical adoption. Major diagnostics and life sciences companies are acquiring proprietary testing platforms to strengthen positions in precision oncology and blood-based diagnostics. AI-enabled genomic workflow ...

Second skin diagnostics refers to the emerging class of ultra-thin, flexible biosensors designed to adhere seamlessly to the skin and continuously monitor a range of physiological signals in real time. Made from stretchable, skin-like materials, these wearables can track vital signs and biomarkers, such as temperature, hydration, glucose, and heart...

The global clinical diagnostics market is poised for strong growth, driven by increased adoption of advanced diagnostics technologies, greater investment in laboratories, and improved access to molecular and immunodiagnostic testing facilities. In 2025, the industry continued its transformation, establishing testing systems as intelligent systems...

10 Jul 2025  |  Global  |  Technology Research

Technologies for Preventing Hospital-Acquired Infections—Innovations and Growth Opportunities

A comprehensive look at the role of AI, automation, and digital surveillance technologies, showcasing the innovations that drives towards real-time detection and prevention strategies of hospital-acquired infections

Infographics

×

Hospital-acquired infections (HAI) occur 48 hours or more after hospital visit and were not present at the time of admission. Globally, around 136 million people are affected by HAIs every year. This increases the mortality rate and economic burden due to extended hospitalization and treatment. This report provides a comprehensive overview of vario...